The Carbon Dioxide (CO2) test measures the concentration of carbon dioxide in the blood, reflecting acid-base balance and respiratory function. It aids in diagnosing and monitoring conditions such as respiratory alkalosis or acidosis, kidney disease, and electrolyte imbalances. Interpretation of CO2 levels helps guide treatment and assess overall patient health.

Risk assessment for the Carbon Dioxide (CO2) test primarily involves ensuring proper sample collection to avoid contamination and maintaining sample integrity. Interpretation considers various factors such as patient's age, medical history, and concurrent medications to accurately assess acid-base balance and respiratory function. Clinicians should be mindful of potential pre-analytical errors and follow established protocols to mitigate risks and ensure reliable results.

The reference range for Carbon Dioxide (CO2) levels in arterial blood typically falls between 35 and 45 millimeters of mercury (mmHg). However, ranges may vary slightly depending on the laboratory and the method of measurement used. Interpretation considers patient demographics and clinical context for accurate assessment of acid-base status.

Interpretation of Carbon Dioxide (CO2) test results involves assessing the measured level of CO2 in the blood. Low CO2 levels may indicate respiratory alkalosis or metabolic acidosis, while high levels may suggest respiratory acidosis or metabolic alkalosis. Clinical correlation with patient symptoms and additional tests is essential for accurate diagnosis and appropriate management.

The Carbon Dioxide (CO2) test typically requires a blood sample collected through arterial puncture, usually from the radial artery in the wrist or the brachial artery in the elbow. Arterial blood gas (ABG) analysis is commonly used to measure CO2 levels. Proper sample collection and handling techniques are crucial to ensure accurate results and minimize pre-analytical errors.